Farmers Trust Co Has Decreased Disney Walt Co (DIS) Holding; National Planning Has Lifted Its Intercept Pharmaceuticals In (ICPT) Stake

Farmers Trust Co decreased Disney Walt Co (DIS) stake by 14.03% reported in 2017Q3 SEC filing. Farmers Trust Co sold 5,657 shares as Disney Walt Co (DIS)’s stock declined 2.31%. The Farmers Trust Co holds 34,674 shares with $3.42 million value, down from 40,331 last quarter. Disney Walt Co now has $163.80B valuation. The stock decreased 0.82% or $0.9 during the last trading session, reaching $108.67. About 7.38M shares traded. The Walt Disney Company (NYSE:DIS) has risen 9.26% since December 25, 2016 and is uptrending. It has underperformed by 7.44% the S&P500.

National Planning Corp increased Intercept Pharmaceuticals In (ICPT) stake by 20.89% reported in 2017Q3 SEC filing. National Planning Corp acquired 10,905 shares as Intercept Pharmaceuticals In (ICPT)’s stock declined 12.60%. The National Planning Corp holds 63,100 shares with $3.66 million value, up from 52,195 last quarter. Intercept Pharmaceuticals In now has $1.58B valuation. The stock increased 0.54% or $0.34 during the last trading session, reaching $62.78. About 468,765 shares traded. Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) has declined 14.52% since December 25, 2016 and is downtrending. It has underperformed by 31.22% the S&P500.

Among 23 analysts covering Intercept Pharmaceuticals (NASDAQ:ICPT), 12 have Buy rating, 2 Sell and 9 Hold. Therefore 52% are positive. Intercept Pharmaceuticals had 65 analyst reports since August 10, 2015 according to SRatingsIntel. The stock of Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) earned “Buy” rating by Wedbush on Monday, July 31. The firm earned “Buy” rating on Friday, September 22 by Cowen & Co. The firm has “Buy” rating given on Tuesday, September 12 by BMO Capital Markets. The company was maintained on Friday, October 20 by Needham. The stock has “Neutral” rating by Goldman Sachs on Tuesday, May 31. As per Wednesday, March 30, the company rating was initiated by Credit Suisse. Laidlaw downgraded the shares of ICPT in report on Friday, August 5 to “Sell” rating. Oppenheimer maintained Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) rating on Monday, July 31. Oppenheimer has “Buy” rating and $20000 target. BMO Capital Markets initiated Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) on Thursday, April 7 with “Outperform” rating. The stock of Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) has “Sell” rating given on Tuesday, September 12 by Cantor Fitzgerald.

National Planning Corp decreased Ishares Tr (IJJ) stake by 2,245 shares to 7,240 valued at $1.11 million in 2017Q3. It also reduced First Tr Exchange (FPE) stake by 89,338 shares and now owns 83,483 shares. Vanguard Index Fds (VBR) was reduced too.

Investors sentiment decreased to 1.33 in 2017 Q3. Its down 0.26, from 1.59 in 2017Q2. It dropped, as 33 investors sold ICPT shares while 30 reduced holdings. 30 funds opened positions while 54 raised stakes. 18.23 million shares or 10.01% less from 20.26 million shares in 2017Q2 were reported. Citadel Advsr Ltd Co holds 0% of its portfolio in Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) for 28,205 shares. Alliancebernstein Lp holds 0% or 9,359 shares. Rhenman & Prns Asset Ab accumulated 0.3% or 40,000 shares. Bancshares Of Montreal Can has 16,470 shares for 0% of their portfolio. Css Lc Il holds 0.02% of its portfolio in Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) for 8,500 shares. Clearbridge Invests Limited Liability Com stated it has 843 shares or 0% of all its holdings. Ohio-based Huntington Bankshares has invested 0% in Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT). Jpmorgan Chase & Co has 0.01% invested in Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT). Deutsche Natl Bank Ag accumulated 211,076 shares. Exane Derivatives holds 0.06% or 5,077 shares. 19,020 are owned by Peak6 L P. Morgan Stanley holds 0% of its portfolio in Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) for 216,736 shares. State Of Wisconsin Inv Board reported 0% stake. Blackrock invested in 0% or 1.16 million shares. Bb Biotech Ag, a Switzerland-based fund reported 485,719 shares.

Analysts await The Walt Disney Company (NYSE:DIS) to report earnings on February, 6. They expect $1.59 earnings per share, up 2.58% or $0.04 from last year’s $1.55 per share. DIS’s profit will be $2.40B for 17.09 P/E if the $1.59 EPS becomes a reality. After $1.07 actual earnings per share reported by The Walt Disney Company for the previous quarter, Wall Street now forecasts 48.60% EPS growth.

Investors sentiment decreased to 0.89 in Q3 2017. Its down 0.20, from 1.09 in 2017Q2. It is negative, as 90 investors sold DIS shares while 649 reduced holdings. 95 funds opened positions while 563 raised stakes. 898.84 million shares or 2.35% less from 920.44 million shares in 2017Q2 were reported. Strategic Advsr Ltd has invested 0.48% in The Walt Disney Company (NYSE:DIS). Foster And Motley reported 9,965 shares. Provise Mgmt Group holds 0.16% or 11,356 shares in its portfolio. Birch Hill Investment Limited Liability owns 0.08% invested in The Walt Disney Company (NYSE:DIS) for 9,737 shares. Gw Henssler And Assoc Ltd owns 199,092 shares. 73,241 are held by Amica Mutual Insur. Baring Asset Mgmt stated it has 12,966 shares or 0.07% of all its holdings. Exxonmobil Investment Mngmt Tx stated it has 281,862 shares. D E Shaw reported 0.12% stake. Andra Ap has invested 0.25% of its portfolio in The Walt Disney Company (NYSE:DIS). Congress Asset Management Ma accumulated 6,048 shares. Hermes Investment Management Limited reported 178,310 shares. Dorsey & Whitney Ltd Limited Liability Company invested 1.56% in The Walt Disney Company (NYSE:DIS). Horan Cap reported 6,083 shares. Raab Moskowitz Asset Lc reported 1.1% in The Walt Disney Company (NYSE:DIS).